<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01514799</url>
  </required_header>
  <id_info>
    <org_study_id>2011_HG_Aleris_limb_length</org_study_id>
    <nct_id>NCT01514799</nct_id>
  </id_info>
  <brief_title>Effects of Long Biliopancreatic Limb vs. Long Alimentary Limb in Superobesity, a Randomized Study</brief_title>
  <official_title>Randomized Study Comparing the Effects of Gastric Bypass Using a Long BP-limb vs. a Long Alimentary Limb in Morbid Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aleris Obesity</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aleris Obesity</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Super Obesity, i.e. a BMI above 50, is difficult to treat. Normal gastric bypass surgery is
      not always enough for proper weight control. Bypassing a longer segment of the gut may be
      more beneficial. Which part to bypass is not clear.

      The investigators want to compare the effects between preventing a 60 cm proximal (oral)
      portion of the jejunum from food contact with the effects when preventing a 200 cm part of
      the jejunum from contact with bile and pancreatic juice.

      Endpoints are quality of life, gastrointestinal function, and weight development.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two variations of gastric bypass are compared:

      Method 1 (test method):A 200 cm BP-limb (distance Treitz to EA) + 150 cm common channel (EA
      to ileocecal valve) + Roux-Y-limb variable Method 2 (standard method): A 60 cm BP limb + 150
      cm Roux-Y-limb + common channel variable.

      Patients are evaluated according to the principles of the Scandinavian Obesity surgery
      registry (SOReg) with the addition of two additional questionnaires.

      FU time is set at 5 years.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 29, 2011</start_date>
  <completion_date type="Actual">February 1, 2020</completion_date>
  <primary_completion_date type="Actual">November 20, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised study between long and standard biliopancreatic limb in gstric bypass surgery</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Randomisation in the OR, (closed envelopes, blocks of six) no further info to ward or follow-up unit. No specific info as to randomisation outcome given to patients, all patients follow same protocol.
Code number in operative charts.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>body weight reduction</measure>
    <time_frame>5 years</time_frame>
    <description>absolute BW reduction, percentage of patients reaching BMI below 30,</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>gastrointestinal function</measure>
    <time_frame>5 years</time_frame>
    <description>SF-36, Op-9, GSRS and TFEQ are used in patient assessed variables</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">140</enrollment>
  <condition>Morbid Obesity</condition>
  <condition>Weight Loss</condition>
  <arm_group>
    <arm_group_label>standard length bp limb, long alimentary limb</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>our normal way of doing a gastric bypass 60 cm BP limb</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Long BP limb</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>200 cm BP limb</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>gastric bypass</intervention_name>
    <description>two techniques of gastric bypass for studying the effects of making a long BP-limb</description>
    <arm_group_label>Long BP limb</arm_group_label>
    <arm_group_label>standard length bp limb, long alimentary limb</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI 50-65

          -  Age 18-55

          -  Conservative attempts at weight reduction failed

        Exclusion Criteria:

          -  Inability to speak and understand the Swedish language

          -  Residence outside the county of Skåne

          -  Psychotic disease

          -  Inflammatory bowel disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan L Hedenbro</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lunds Universitets Diabetescentrum</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aleris Obesity Skåne</name>
      <address>
        <city>Lund</city>
        <zip>SE 222 70</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>January 18, 2012</study_first_submitted>
  <study_first_submitted_qc>January 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2012</study_first_posted>
  <last_update_submitted>February 24, 2020</last_update_submitted>
  <last_update_submitted_qc>February 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>gastric bypass</keyword>
  <keyword>morbid obesity</keyword>
  <keyword>gut function</keyword>
  <keyword>weight loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
    <mesh_term>Weight Loss</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

